Solid Biosciences Inc (SLDB)
10.25
-0.17
(-1.63%)
USD |
NASDAQ |
May 08, 16:00
10.26
0.00 (0.00%)
After-Hours: 20:00
Solid Biosciences Enterprise Value: 264.43M for May 8, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 08, 2024 | 264.43M |
| May 07, 2024 | 270.87M |
| May 06, 2024 | 254.97M |
| May 03, 2024 | 258.75M |
| May 02, 2024 | 263.68M |
| May 01, 2024 | 237.55M |
| April 30, 2024 | 212.18M |
| April 29, 2024 | 209.16M |
| April 26, 2024 | 216.35M |
| April 25, 2024 | 199.69M |
| April 24, 2024 | 208.40M |
| April 23, 2024 | 221.27M |
| April 22, 2024 | 218.62M |
| April 19, 2024 | 205.75M |
| April 18, 2024 | 226.95M |
| April 17, 2024 | 254.59M |
| April 16, 2024 | 248.15M |
| April 15, 2024 | 254.97M |
| April 12, 2024 | 268.70M |
| April 11, 2024 | 279.67M |
| April 10, 2024 | 286.10M |
| April 09, 2024 | 313.72M |
| April 08, 2024 | 326.96M |
| April 05, 2024 | 336.42M |
| April 04, 2024 | 344.74M |
| Date | Value |
|---|---|
| April 03, 2024 | 350.04M |
| April 02, 2024 | 334.15M |
| April 01, 2024 | 347.01M |
| March 28, 2024 | 379.28M |
| March 27, 2024 | 414.40M |
| March 26, 2024 | 388.72M |
| March 25, 2024 | 389.10M |
| March 22, 2024 | 395.52M |
| March 21, 2024 | 352.85M |
| March 20, 2024 | 377.39M |
| March 19, 2024 | 433.27M |
| March 18, 2024 | 380.79M |
| March 15, 2024 | 370.22M |
| March 14, 2024 | 340.01M |
| March 13, 2024 | 338.13M |
| March 12, 2024 | 306.79M |
| March 11, 2024 | 307.17M |
| March 08, 2024 | 296.97M |
| March 07, 2024 | 259.97M |
| March 06, 2024 | 232.03M |
| March 05, 2024 | 235.05M |
| March 04, 2024 | 239.32M |
| March 01, 2024 | 242.31M |
| February 29, 2024 | 228.08M |
| February 28, 2024 | 230.33M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-142.48M
Minimum
Mar 21 2023
757.86M
Maximum
Mar 02 2021
72.31M
Average
53.61M
Median
Sep 28 2020
Enterprise Value Benchmarks
| Sarepta Therapeutics Inc | 12.38B |
| PTC Therapeutics Inc | 1.788B |
| Capricor Therapeutics Inc | 129.68M |
| Perspective Therapeutics Inc | 1.025B |
| Electromed Inc | 136.54M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -20.34M |
| Total Expenses (Quarterly) | 22.26M |
| EPS Diluted (Quarterly) | -1.00 |
| Earnings Yield | -47.22% |
| Normalized Earnings Yield | -110.78 |